Five Years Follow-Up after 2-Chloro Deoxyadenosine Treatment in Thirty Patients with Hairy Cell Leukemia: Evaluation of Minimal Residual Disease and CD4+ Lymphocytopenia after Treatment
Jean Bastié(Centre Hospitalier Universitaire Dijon Bourgogne), Sylvie Castaigné(Hôpital André Mignot), Dominique Poisson(Janssen (France)), C. Rabian(Hôpital Saint-Louis), Georges Flandrin(Inserm), Sylvie Glaisner(Hôpital René Huguenin), Dominique Cazals‐Hatem(Hôpital Saint-Louis), Marie-Pierre Noël-Walter(Hôpital Claude Huriez), L Degos(Centre Hospitalier Universitaire de Lille), MT Daniel, Hervé Dombret(University of London Institute in Paris), M F D'Agay(Hôpital Saint-Louis), D. Dabout(Janssen (France))
Cited by 52
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k